The federal government is trying to make it easier for immunocompromised patients access a treatment that can protect them against COVID-19 by allowing individual health care providers to order small amounts — up to three patient courses at a time, according to a Health and Human Services Department spokesperson.
“This new pathway will be particularly beneficial for health care providers in rural areas and others that do not have a large pool of patients requiring the therapy,” the spokesperson said.
In addition, Evusheld will be available through a subset of federal pharmacy partners, including Albertsons, Acme, Jewel-Osco, Pavilions, Randalls, Safeway, Star Market, and Vons, CPESN, Hy-Vee, Amber Specialty Pharmacy, Managed Healthcare Associates and Thrifty White.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
